152 related articles for article (PubMed ID: 9378061)
1. [Initial administration of a protease inhibitor delays the progression of AIDS by half time].
Dtsch Med Wochenschr; 1997 Oct; 122(42):A27. PubMed ID: 9378061
[No Abstract] [Full Text] [Related]
2. Therapy of HIV infections: problems and prospects.
Ho DD
Bull N Y Acad Med; 1996; 73(1):37-45. PubMed ID: 8804736
[No Abstract] [Full Text] [Related]
3. Treatment of late-state HIV infection.
Millard PS
J Fam Pract; 1997 Feb; 44(2):132-4. PubMed ID: 9040512
[No Abstract] [Full Text] [Related]
4. [Therapeutic strategies against HIV: status in 1994 and future prospectives].
Internist (Berl); 1994 Jul; 35(7 Suppl):1-24. PubMed ID: 9131074
[No Abstract] [Full Text] [Related]
5. [Anti-HIV therapy (1987-1994): from nothing to confusion].
Lissen E
Med Clin (Barc); 1995 Apr; 104(12):463-7. PubMed ID: 7739285
[No Abstract] [Full Text] [Related]
6. ddI and d4T plus protease inhibitors.
GMHC Treat Issues; 1996 Nov; 10(11):8-9. PubMed ID: 11364012
[TBL] [Abstract][Full Text] [Related]
7. The Delta trial.
Zaretsky MD
Lancet; 1997 Feb; 349(9048):358-9. PubMed ID: 9024402
[No Abstract] [Full Text] [Related]
8. Update on nevirapine: quest for a niche.
MacDougall DS
J Int Assoc Physicians AIDS Care; 1997 Sep; 3(9):37-43. PubMed ID: 11364713
[TBL] [Abstract][Full Text] [Related]
9. [Combination therapies with anti-retroviral agents in HIV and AIDS infections].
Fernández-Cruz E
Rev Clin Esp; 1991 Oct; 189(6):253-5. PubMed ID: 1722345
[No Abstract] [Full Text] [Related]
10. [Mononucleosis syndrome with viro-immunologic parameters similar to those of a primary HIV-1 infection after interruption of highly effective anti-retroviral treatment].
Orbea Ríos L; Domínguez Castellanos A; Justo Alpañés E
An Med Interna; 2002 Jun; 19(6):321-2. PubMed ID: 12152394
[No Abstract] [Full Text] [Related]
11. [Antiretroviral treatment in human immunodeficiency virus infection].
Blum L; Bachmeyer C
Ann Dermatol Venereol; 1997; 124(9):641-54. PubMed ID: 9739932
[No Abstract] [Full Text] [Related]
12. Treatment options for human immunodeficiency virus.
Heins JR
S D J Med; 1996 Feb; 49(2):51-2. PubMed ID: 9122670
[No Abstract] [Full Text] [Related]
13. Drugs for HIV infection.
Med Lett Drugs Ther; 1997 Dec; 39(1015):111-6. PubMed ID: 9402928
[No Abstract] [Full Text] [Related]
14. Top AIDS researchers' strategy for antiretroviral treatment.
AIDS Alert; 1996 Sep; 11(9):97-100. PubMed ID: 11363728
[TBL] [Abstract][Full Text] [Related]
15. [Initial anti-retroviral treatment (therapeutic approach to patients without previous treatment)].
Gatell JM; Guerra L; Pérez-Elías MJ; Santamaría JM
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():20-3. PubMed ID: 9053022
[No Abstract] [Full Text] [Related]
16. [Early treatment of sexual exposure to human immunodeficiency virus].
Derancourt C; Drobacheff C; Verraes S; Beguinot I; Bernard P
Ann Dermatol Venereol; 2000 Jan; 127(1):122-4. PubMed ID: 10717578
[No Abstract] [Full Text] [Related]
17. Protease inhibitors and prevention of cross resistance.
Levin J
AIDS Treat News; 1995 Oct; (no 232):1-3. PubMed ID: 11362875
[TBL] [Abstract][Full Text] [Related]
18. Indinavir gender study shows consistency.
AIDS Patient Care STDS; 1998 Dec; 12(12):940-1. PubMed ID: 11362069
[No Abstract] [Full Text] [Related]
19. A multicentre study to determine the efficacy and tolerability of a combination of nelfinavir (VIRACEPT), zalcitabine (HIVID) and zidovudine in the treatment of HIV infected Nigerian patients.
Idoko JA; Akinsete L; Abalaka AD; Keshinro LB; Dutse L; Onyenekwe B; Lhekwaba A; Njoku OS; Kehinde MO; Wambebe CO
West Afr J Med; 2002; 21(2):83-6. PubMed ID: 12403023
[TBL] [Abstract][Full Text] [Related]
20. [Anti-retroviral treatment. Approach to previously treated patients].
Antela A; Podzamczer D; Ruiz I; Parras F
Enferm Infecc Microbiol Clin; 1996 Oct; 14 Suppl 1():24-30. PubMed ID: 9053023
[No Abstract] [Full Text] [Related]
[Next] [New Search]
